Immune checkpoint inhibitors against the PD-1/PD-L1 interaction as therapeutics for various cancers have achieved great success. However, about 70% of patients do not respond well when receiving ...
Identification of potent COVID-19 main protease inhibitors by loading of favipiravir on Mg12O12 and Zn12O12 nanoclusters: an in silico strategy for COVID-19 treatment.